News and Announcements
DMX Address Understanding of ‘What Investors Are Hoping For’
- Published March 07, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Understanding what the market is expecting from a company is a key input in DMCX investment process. The company looks for under-appreciated stocks where valuation reflects the markets low expectations for the business. As a result, DMX look to gauge market expectations before investing and look to broker reports, investor discussions, online stock discussions forums and subscription research services to better understand what the market is really expecting from a company.
KEY TAKEAWAYS:
- Start with the stock’s valuation: Viewing a stock’s current market valuation as a great starting point in gauging what the market is expecting from a company looking forward.
- More information required since the smaller companies market is inefficient: One of the great attractions of investing in smaller companies in the ineffective nature of the smaller companies’ market.
- Listen to the loudest opinions and take them with a grain of salt: DMX explains from their experiences, listening to the market voices can add significant value when gauging market expectations.
- Management engagement and communication.
- Use the noise to ultimately ignore the noise: think long term.
Gauging expectations is core to value investors’ psyches since DMX are looking for stocks which are largely ignored and under-appreciated, and thus under-valued. Low expectations is near the top of DMXs’ shopping list of the attributes of high quality, under-valued smaller companies we are looking for. DMX will continue to focus on stocks where expectations are low to our shareholders’ benefit.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
